Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release
- PMID: 1533382
- DOI: 10.1055/s-2007-1003255
Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release
Abstract
The effects of CRF administration on cardiac performance, coronary flow and ANP release were investigated in the rat heart. Isolated hearts were perfused at a constant filling pressure according to working heart model with a Krebs-Henseleit solution containing glucose and insulin, saturated with a gas mixture containing 95% O2 and 5% CO2. Administration of CRF via a cannula into the left atrium elicited a prolonged increase in the coronary flow rate and a transient increase in the aortic pressure resulting in an overall increase in the pressure-volume work. The oxygen consumption, after the administration of CRF, increased in accordance with the cardiac effort. No changes were observed in the spontaneous heart rate. Furthermore, administration of CRF induced a short-term increase of ANP release into the coronary perfusate. Our experiments suggest that administration of CRF produces a prolonged dilatory effect on the coronary arteries while producing a transient positive inotropic effect and a transient increase of ANP release on the isolated rat heart.
Similar articles
-
Effect of corticotropin releasing factor on atrial natriuretic peptide release from the isolated perfused rat heart.Arzneimittelforschung. 1994 May;44(5):579-82. Arzneimittelforschung. 1994. PMID: 8024626
-
Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.J Mol Cell Cardiol. 1994 Apr;26(4):527-37. doi: 10.1006/jmcc.1994.1063. J Mol Cell Cardiol. 1994. PMID: 8072008
-
The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent.Eur J Pharmacol. 2008 Jan 14;578(2-3):242-8. doi: 10.1016/j.ejphar.2007.09.018. Epub 2007 Oct 2. Eur J Pharmacol. 2008. PMID: 17936748
-
Effects of corticotropin-releasing factor on isolated rat heart activity.Am J Physiol. 1993 Apr;264(4 Pt 2):H1124-9. doi: 10.1152/ajpheart.1993.264.4.H1124. Am J Physiol. 1993. PMID: 8476089
-
Regulation of coronary blood flow during exercise.Physiol Rev. 2008 Jul;88(3):1009-86. doi: 10.1152/physrev.00045.2006. Physiol Rev. 2008. PMID: 18626066 Review.
Cited by
-
A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1108-12. doi: 10.1073/pnas.92.4.1108. Proc Natl Acad Sci U S A. 1995. PMID: 7755719 Free PMC article.
-
Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases.Mol Cell Biochem. 2003 Oct;252(1-2):25-32. doi: 10.1023/a:1025551305777. Mol Cell Biochem. 2003. PMID: 14577573
-
Corticotropin-releasing factor signaling and visceral response to stress.Exp Biol Med (Maywood). 2010 Oct;235(10):1168-78. doi: 10.1258/ebm.2010.009347. Exp Biol Med (Maywood). 2010. PMID: 20881321 Free PMC article. Review.
-
Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease.Int J Endocrinol. 2012;2012:198628. doi: 10.1155/2012/198628. Epub 2012 Apr 3. Int J Endocrinol. 2012. PMID: 22548056 Free PMC article.
-
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2969-73. doi: 10.1073/pnas.92.7.2969. Proc Natl Acad Sci U S A. 1995. PMID: 7708757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources